Actinium Pharmaceuticals, Inc. ( ATNM) - Key Metrics
ATNM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.11 | $0.89 | -$0.16 | -$0.18 |
| 2026Q1 | $0 | -$0.18 | -$0.19 | -$0.19 |
| 2025Q4 | $0 | -$0.19 | -$0.17 | -$0.17 |
| 2025Q3 | $0 | -$0.16 | -$0.20 | -$0.20 |
| 2025Q2 | $0 | -$0.22 | -$0.17 | -$0.17 |
ATNM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 0.28 |
| 2026Q1 | 0% | -1.38 |
| 2025Q4 | 0% | -1.79 |
| 2025Q3 | 0% | -2.50 |
| 2025Q2 | 0% | -1.59 |
ATNM
Price: $1.13
52 week price:
Earnings Per Share: -0.76 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 219900
Market Capitalization: 37.6 million